Filtros de búsqueda

Lista de obras de Elena Fumagalli

A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors

artículo científico publicado en 2009

Activate and resist: L576P-KIT in GIST.

artículo científico publicado en 2009

Adjuvant therapy of gastrointestinal stromal tumors (GIST).

artículo científico

Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib

artículo científico publicado en 2013

Carney triad can be (rarely) associated with germline succinate dehydrogenase defects

scientific article published on 15 July 2015

Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib

artículo científico publicado en 2015

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib

artículo científico publicado en 2017

Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.

artículo científico publicado en 2002

Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer

artículo científico publicado en 2001

Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome

artículo científico publicado en 2014

Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST.

artículo científico publicado en 2017

High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma

artículo científico publicado en 2014

Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis

artículo científico publicado en 2015

Imatinib mesylate in chordoma

artículo científico publicado en 2004

Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling study

artículo científico publicado en 2011

Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?

artículo científico publicado en 2008

Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).

artículo científico publicado en 2014

Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland

artículo científico publicado en 2005

Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience

artículo científico publicado en 2013

Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs).

artículo científico publicado en 2009

Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.

artículo científico publicado en 2012

Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy

artículo científico publicado en 2012

Population Pharmacokinetic/Pharmacodynamic Modeling of Sunitinib by Dosing Schedule in Patients with Advanced Renal Cell Carcinoma or Gastrointestinal Stromal Tumor

artículo científico publicado en 2016

Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour

artículo científico publicado en 2014

Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).

artículo científico publicado en 2008

Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy

artículo científico publicado en 2011

Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib

scientific article published on 01 April 2020

Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

artículo científico publicado en 2019

Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients.

artículo científico publicado en 2001

Stimulation of IL-18 secretion by IL-2 in patients with advanced cancer

artículo científico publicado en 2001

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointesti

artículo científico publicado en 2017

Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomi

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda